Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $5,082.00 |
|---|---|
| Enterprise Value | $365,860.00 |
| Earnings per Share | $0 |
| Beta | 0.88 |
| Outstanding Shares | 50,818,525 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.95 |
| Enterprise Value to EBIT | -0.45 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.23 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Rejuvel Bio-Sciences, Inc. is a development-stage firm operating globally, primarily involved in the production, distribution, and marketing of skincare products. Its main offering is a skin cream sold under the Rejuvel brand. Additional...